Literature DB >> 1269514

[Studies on the value of fecal tryptic and chymotryptic activity in the diagnosis and therapy of cystic fibrosis (author's transl)].

J Weise, Y Kobayashi, W Tolckmitt.   

Abstract

Under certain conditions the determination of the tryptic activity, especially of the chymotryptic activity in the feces mostly of infants in the first 4-6 weeks of life is considered to be an important step in the diagnosis of cystic fibrosis. The tryptic anc chymotryptic activity in the feces of children with cystic fibrosis declines when the substitution of pancreatic enzymes is stopped. On resubstitution, the activity rises in relation to the dose and attains the activity related to age as found in healthy children. A comparison of the proteolytic activity with the fat content of the feces during the study period without the enzyme substitution and during the period when the enzyme dosage varied showed no significant correlation. It is not possible to postulate a poor excretion of fats merely from the high proteolytic activity of the feces because the fecal proteolytic activity and the fat excretion are not inversely proportional to one another. For this reason, one cannot conclude that the grade of the proteolytic activity in the feces of patients with cystic fibrosis is a yardstick for the total digestive process when they are under pancreatic enzyme substitution.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269514     DOI: 10.1007/BF00466269

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Mucoviscidosis.

Authors:  H SHWACHMAN; H LEUBNER; P CATZEL
Journal:  Adv Pediatr       Date:  1955

2.  Pancreatic replacement therapy in fibrocystic disease.

Authors:  R D HAINES; N C HIGHTOWER; W A CROZIER; J M EIBAND
Journal:  JAMA       Date:  1962-06-23       Impact factor: 56.272

3.  Fat absorption studies in the diagnosis and treatment of pancreatic fibrosis.

Authors:  C A ROSS
Journal:  Arch Dis Child       Date:  1955-08       Impact factor: 3.791

4.  Trypsin and chymotrypsin in duodenal aspirate and faeces in response to secretin and cholecystokinin-pancreozymin.

Authors:  J K Sale; D M Goldberg; B Thjodleifsson; K G Wormsley
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

5.  Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.

Authors:  A Lapey; J Kattwinkel; P A Di Sant'Agnese; L Laster
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

6.  [Resorption of fat with and without pancreas enzyme substitution in children with mucoviscidosis (author's transl)].

Authors:  K H Niessen; G Brügmann; K Schmidt; P Osswald; N Drees
Journal:  Klin Padiatr       Date:  1973-07       Impact factor: 1.349

7.  Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion.

Authors:  D H Shmerling; J C Forrer; A Prader
Journal:  Pediatrics       Date:  1970-11       Impact factor: 7.124

8.  Tryptic and chymotryptic activity of stools of newborn infants.

Authors:  M Mullinger; M Palasi
Journal:  Pediatrics       Date:  1966-10       Impact factor: 7.124

9.  Stool trypsin and chymotrypsin. Value in the diagnosis of pancreatic insufficiency in cystic fibrosis.

Authors:  G J Barbero; M S Sibinga; J M Marino; R Seibel
Journal:  Am J Dis Child       Date:  1966-12

10.  [Tryptic and chymotryptic activity in the faeces of children of different age groups (author's transl)].

Authors:  K Sälzer; Y Kobayashi; W Tolckmitt
Journal:  Eur J Pediatr       Date:  1976-03-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.